sarscov
express
sever
structur
protein
includ
nucleocapsid
membran
envelop
spike
protein
may
serv
antigen
induc
neutral
antibodi
protect
respons
gener
prior
identif
protein
contain
major
neutral
epitop
inactiv
viru
may
use
firstgener
vaccin
easi
gener
whole
kill
viru
particl
howev
neutral
epitop
identifi
inactiv
viru
vaccin
replac
vaccin
base
fragment
contain
neutral
epitop
sinc
safer
effect
sever
report
show
sarscov
inactiv
formaldehyd
uv
light
induc
virusneutr
antibodi
immun
anim
first
inactiv
sarscov
vaccin
test
clinic
trial
china
howev
safeti
inactiv
vaccin
seriou
concern
product
worker
risk
infect
handl
concentr
live
sarscov
incomplet
viru
inactiv
may
caus
sar
outbreak
among
vaccin
popul
viral
protein
may
induc
harm
immun
inflammatori
respons
even
caus
sarslik
diseas
protein
sarscov
type
transmembran
glycoprotein
respons
viru
bind
fusion
entri
major
induc
neutral
antibodi
protein
consist
signal
peptid
sp
amino
acid
aa
domain
extracellular
domain
aa
transmembran
domain
aa
intracellular
domain
aa
extracellular
domain
consist
subunit
although
cleavag
site
subunit
clearli
defin
subunit
respons
viru
bind
receptor
angiotensinconvert
enzym
fragment
locat
middl
region
subunit
aa
receptorbind
domain
rbd
sarscov
may
also
bind
cell
altern
receptor
dcsign
lsign
bind
site
altern
receptor
defin
subunit
contain
put
fusion
peptid
heptad
repeat
respons
fusion
viral
target
cell
membran
infect
sarscov
initi
bind
rbd
viral
protein
subunit
target
cell
form
fusogen
core
region
domain
bring
viral
target
cell
membran
close
proxim
result
viru
fusion
entri
scenario
indic
protein
may
use
vaccin
induc
antibodi
block
viru
bind
fusion
sever
recombin
vectorbas
vaccin
express
sarscov
protein
assess
preclin
studi
yang
et
al
report
candid
dna
vaccin
encod
fulllength
protein
induc
neutral
antibodi
neutral
titer
rang
protect
mice
sarscov
challeng
use
dna
vaccin
encod
fulllength
segment
protein
immun
rabbit
wang
et
al
produc
higher
titer
neutral
antibodi
demonstr
major
minor
neutral
epitop
locat
subunit
respect
group
also
found
neutral
epitop
subunit
bisht
et
al
shown
intranas
intramuscular
inocul
mice
highli
attenu
modifi
vaccinia
viru
ankara
mva
vaccin
encod
fulllength
sarscov
protein
also
produc
neutral
antibodi
mean
neutral
titer
bukreyev
et
al
report
mucos
immun
african
green
monkey
attenu
parainfluenza
viru
express
protein
result
product
neutral
antibodi
protect
anim
infect
challeng
sarscov
data
suggest
protein
induc
neutral
antibodi
protect
respons
immun
anim
use
convalescentphas
sera
sar
patient
set
peptid
span
entir
sequenc
sarscov
protein
identifi
linear
immunodomin
site
id
protein
figur
id
ii
iii
v
react
convalescentphas
sera
sar
patient
id
iv
reactiv
sar
sera
suggest
id
iv
major
immunodomin
epitop
protein
synthet
peptid
correspond
id
could
induc
high
titer
antibodi
none
antibodi
possess
neutral
activ
find
suggest
id
protein
may
induc
neutral
antibodi
whether
antibodi
enhanc
infect
heterolog
sarscov
strain
mediat
harm
immun
respons
unclear
protein
fipv
express
recombin
vaccinia
caus
antibodydepend
enhanc
diseas
vaccin
anim
subsequ
infect
wildtyp
viru
previou
studi
show
antibodi
immunodomin
epitop
envelop
glycoprotein
could
enhanc
infect
heterolog
strain
recent
yang
et
al
demonstr
polyclon
monoclon
antibodi
protein
late
sarscov
urbani
strain
could
neutral
infect
relev
late
sarscov
strain
howev
antibodi
enhanc
infect
earli
human
sarscov
isol
civet
virus
investig
shown
domain
mediat
antibodydepend
enhanc
civet
viru
entri
theoret
antibodi
domain
may
enhanc
infect
antibodi
close
mimic
receptor
induc
similar
conform
chang
receptor
like
protein
truncat
aa
fail
caus
antibodydepend
enhanc
infect
although
still
induc
neutral
antibodi
find
suggest
remov
aa
region
may
abrog
induct
viru
antibodi
vaccin
ferret
mvabas
sar
vaccin
express
fulllength
protein
caus
liver
damag
anim
challeng
sarscov
find
rais
concern
efficaci
safeti
vaccin
contain
express
fulllength
protein
rbd
fragment
aa
residu
middl
subunit
protein
figur
respons
viru
bind
receptor
target
cell
demonstr
antisera
sar
patient
anim
immun
inactiv
sarscov
react
strongli
rbd
absorpt
antibodi
rbd
antisera
result
remov
neutral
antibodi
rbdspecif
antibodi
isol
antisera
potent
neutral
activ
also
shown
rabbit
mice
immun
rbd
produc
high
titer
neutral
antibodi
sarscov
neutral
titer
serum
dilut
immun
mice
protect
sarscov
challeng
unpub
data
antibodi
purifi
antisera
sarscov
significantli
inhibit
rbd
bind
use
spleen
cell
mice
immun
rbd
gener
panel
monoclon
antibodi
mab
recogn
differ
conform
epitop
rbd
possess
potent
neutral
activ
result
agreement
report
van
den
brink
et
al
identifi
human
neutral
anti
mab
antibodi
phage
display
librari
use
inactiv
sarscov
target
research
also
found
mab
specif
bound
rbd
block
interact
rbd
find
suggest
rbd
contain
major
neutral
epitop
protein
ideal
sar
vaccin
candid
rbd
contain
receptorbind
site
critic
viru
attach
target
cell
infect
antibodi
specif
rbd
expect
block
bind
viru
target
cell
rbd
induc
higher
titer
neutral
antibodi
vaccin
express
fulllength
protein
rbd
sequenc
among
late
sarscov
strain
highli
conserv
earli
late
sarscov
strain
compar
aa
residu
variabl
among
residu
rbd
isol
vari
residu
van
den
brink
et
al
show
human
mab
specif
rbd
sarscov
strain
effect
bind
rbd
earli
late
sarscov
strain
data
suggest
antibodi
direct
rbd
sarscov
isol
may
neutral
infect
broad
spectrum
sarscov
strain
therefor
recombin
protein
contain
rbd
vector
encod
rbd
may
use
vaccin
prevent
infect
sarscov
distinct
genotyp
ideal
sar
vaccin
elicit
highli
potent
neutral
antibodi
respons
broad
spectrum
viral
strain
induc
protect
infect
transmiss
safe
induc
infectionenhanc
antibodi
harm
immun
inflammatori
respons
current
inactiv
sarscov
vaccin
clinic
trial
china
safeti
major
concern
type
vaccin
protein
major
induc
neutral
antibodi
recombin
vectorbas
vaccin
express
fulllength
protein
late
sarscov
develop
vaccin
induc
potent
neutral
protect
respons
immun
anim
may
induc
antibodi
enhanc
infect
earli
human
sarscov
anim
virus
recent
studi
demonstr
recombin
rbd
consist
multipl
conform
neutral
epitop
induc
highli
potent
neutral
antibodi
sarscov
unlik
fulllength
protein
rbd
contain
immunodomin
site
induc
nonneutr
antibodi
rbd
sequenc
rel
conserv
thu
recombin
rbd
vector
encod
rbd
may
use
safe
efficaci
vaccin
prevent
infect
sarscov
distinct
genotyp
